Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Financial Flexibility Index
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Financial Flexibility Index of 0.49x as of December 2025. Free cash flow of $68.82 Million (operating CF $41.05 Million minus capex $27.77 Million) represents 0% of total liabilities ($140.71 Million). Check ZYBT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhengye Biotechnology Holding Limited Ordinary Shares Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. For the full cash flow conversion analysis, see ZYBT cash flow conversion.
Annual Financial Flexibility Index for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year free cash flow to debt coverage for Zhengye Biotechnology Holding Limited Ordinary Shares. Explore ZYBT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | $68.82 Million | $41.05 Million | $140.71 Million | ▲ +0.0% |
| 2024 | 0.49x | $68.82 Million | $41.05 Million | $140.71 Million | ▲ +31.4% |
| 2023 | 0.37x | $59.78 Million | $48.18 Million | $160.62 Million | ▲ +35.7% |
| 2022 | 0.27x | $44.66 Million | $17.34 Million | $162.81 Million | ▼ -40.4% |
| 2021 | 0.46x | $58.20 Million | $31.81 Million | $126.44 Million | — |